Fiere D - Search Results

1

Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity.

Thomas X, Anglaret B, Adeleine P, Maritaz O, Bailly M, Fiere D, Archimbaud E. Thomas X, et al. Among authors: fiere d. Leuk Lymphoma. 1998 Jan;28(3-4):343-53. doi: 10.3109/10428199809092689. Leuk Lymphoma. 1998. PMID: 9517505

2

Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome.

Thomas X, Hirschauer C, Troncy J, Assouline D, Joly MO, Fiere D, Archimbaud E. Thomas X, et al. Among authors: fiere d. Leuk Lymphoma. 1997 Jan;24(3-4):291-300. doi: 10.3109/10428199709039016. Leuk Lymphoma. 1997. PMID: 9156658

3

Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

Archimbaud E, Thomas X, Campos L, Magaud JP, Doré JF, Fiere D. Archimbaud E, et al. Among authors: fiere d. Leukemia. 1992 Apr;6(4):265-71. Leukemia. 1992. PMID: 1375302

4

Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.

Archimbaud E, Thomas X, Campos L, Fiere D, Doré JF. Archimbaud E, et al. Among authors: fiere d. Leuk Res. 1992 Jun-Jul;16(6-7):673-80. doi: 10.1016/0145-2126(92)90018-3. Leuk Res. 1992. PMID: 1378919

5

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.

Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Doré JF. Archimbaud E, et al. Among authors: fiere d. Leukemia. 1991 Nov;5(11):967-71. Leukemia. 1991. PMID: 1961038

6

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.

Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. Thomas X, et al. Among authors: fiere d. Leukemia. 1995 Feb;9(2):249-53. Leukemia. 1995. PMID: 7532767

7

Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.

Archimbaud E, Charrin C, Magaud JP, Campos L, Thomas X, Fière D, Rimokh R. Archimbaud E, et al. Among authors: fiere d. Leukemia. 1998 Jan;12(1):25-33. doi: 10.1038/sj.leu.2400853. Leukemia. 1998. PMID: 9436917

8

Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study.

Belhabri A, Thomas X, Troncy J, Assouline D, Michallet M, Wattel E, Tigaud JD, Blanc M, Fière D, Archimbaud E. Belhabri A, et al. Among authors: fiere d. Leuk Lymphoma. 1999 Dec;36(1-2):45-55. doi: 10.3109/10428199909145948. Leuk Lymphoma. 1999. PMID: 10613449 Clinical Trial.

9

Prognostic Factors in Acute Promyelocytic Leukemia: A Retrospective Study of 67 Cases.

Thomas X, Archimbaud E, Treille-Ritouet D, Fiere D. Thomas X, et al. Among authors: fiere d. Leuk Lymphoma. 1991;4(4):249-56. doi: 10.3109/10428199109068073. Leuk Lymphoma. 1991. PMID: 27463044

10

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

Archimbaud E, Anglaret B, Thomas X, Devaux Y, Ffrench M, Sebban C, Troncy J, Fiere D. Archimbaud E, et al. Among authors: fiere d. Leukemia. 1992 Aug;6(8):776-9. Leukemia. 1992. PMID: 1640728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters